CRS operates in the steel production industry, focusing on integrated steel-making processes.
It is an established industry participant whose core characteristics are tied to the cyclical nature and capital-intensive operations of the steel sector.
Updated: February 19, 2026, 16:00 EST
Based on a comprehensive analysis of Carpenter Technology Corporation (CRS), the stock presents a conflicting picture. Technically, it shows strong bullish momentum and a robust recovery, while fundamentally, the company exhibits solid profitability and a healthy balance sheet. However, extreme valuation multiples pose a significant concern.
Technical Analysis: CRS exhibits exceptionally strong momentum, with double-digit recent gains and a remarkable recovery from its 52-week lows. However, its high beta indicates higher volatility, and trading near its 52-week high suggests it may be overbought in the short term.
Fundamental Analysis: The company demonstrates solid financial health with a strong liquidity position and conservative debt levels. Profitability has improved through effective cost control, although a slight revenue decline and operational inefficiencies, like a lengthy cash conversion cycle, are noted areas for improvement.
Valuation & Risk: The primary concern is extreme overvaluation, with a TTM P/E of 42.94 and a negative PEG ratio, indicating earnings growth does not justify the high price. The stock's high volatility also presents a notable risk for substantial drawdowns.
Recommendation: Despite strong operational fundamentals and positive technical momentum, CRS's valuation appears excessively stretched. The high P/E and negative PEG ratio suggest significant downside risk if growth fails to materialize. Given the clear overvaluation, a Buy recommendation is not justified at this time; investors should wait for a more attractive entry point or clearer signs of earnings acceleration.
*This is not investment advice, for reference only.*
Based on the provided analysis, here is a 12-month outlook for Carpenter Technology (CRS):
The primary catalysts for CRS over the next year are its strong operational fundamentals, including solid profitability and a healthy balance sheet, which could support growth if end-market demand in the aerospace and defense sectors remains robust. However, the most significant risk is its extreme valuation, with a high P/E and negative PEG ratio creating substantial downside potential if earnings growth fails to accelerate or momentum wanes. Given the stock is trading near its 52-week high with overbought technical signals, the outlook is cautious; investors should wait for a more attractive entry point, with a price range potentially consolidating or pulling back from the current level of $373.73 to better reflect its fundamental value.
Most Wall Street analysts are optimistic about Carpenter Technology Corporation's 12-month outlook, with consensus target around $383.98, indicating expected upside potential.
Overall, CRS has investment potential but also faces challenges. Here are key factors to weigh before investing.
CRS has demonstrated exceptionally strong bullish momentum over the past year, significantly recovering from its 52-week lows to approach new highs. This performance has been characterized by substantial double-digit gains in recent months.
The stock exhibits robust short-term momentum with significant outperformance, gaining 11.41% over one month and 12.57% over three months while outperforming the market by 12.15% during the latter period. Its beta of 1.267 confirms the stock has experienced higher volatility than the broader market, which has amplified these strong returns.
CRS currently trades near the upper end of its 52-week range at approximately 96% of its yearly high, indicating an overbought condition from a technical perspective. Despite experiencing a maximum drawdown of -28.11% within the past year, the stock has demonstrated remarkable resilience and recovery to reach current elevated levels.
| Period | CRS Return | S&P 500 |
|---|---|---|
| 1m | +15.5% | +1.0% |
| 3m | +18.2% | +1.9% |
| 6m | +49.2% | +6.5% |
| 1y | +84.6% | +12.1% |
| ytd | +13.5% | +0.2% |
Revenue & Profitability Revenue declined slightly from $733.7 million to $728 million quarter-over-quarter, reflecting modest top-line pressure. However, profitability strengthened, with the net profit margin improving to 14.5% from 16.7% in the prior quarter, driven by a higher gross profit ratio of 30.0%. This indicates effective cost control despite the minor revenue contraction.
Financial Health The company maintains a strong liquidity position with a current ratio of 4.25 and a robust interest coverage ratio of 15.2, signaling minimal near-term solvency risk. The debt-to-equity ratio of 0.35 is conservative, and the cash flow to debt ratio of 0.19 suggests sufficient operational cash flow to service obligations, underscoring a solid balance sheet.
Operational Efficiency CRS demonstrates moderate operational efficiency, with an ROE of 5.3% and an asset turnover of 0.21, indicating room for improvement in generating returns from its asset base. The lengthy cash conversion cycle of 172 days, driven by high days inventory outstanding (145 days), points to potential inefficiencies in working capital management that could be optimized.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardBased on the available valuation metrics, CRS appears significantly overvalued. The TTM P/E ratio of 42.94 and forward P/E of 37.45 are exceptionally high, suggesting investors are paying a substantial premium for current earnings. This overvaluation is further supported by the deeply negative PEG ratio of -2.62, which indicates that earnings growth is either negative or not keeping pace with the high P/E multiple, and an extremely elevated EV/EBITDA of 92.1, signaling poor cash flow generation relative to the company's enterprise value.
A peer comparison cannot be performed due to the unavailability of industry average data. This lack of contextual benchmarks makes it difficult to determine if CRS's high multiples are an industry-wide phenomenon or specific to the company. Consequently, the assessment of overvaluation is based solely on the absolute level of the metrics, which are alarmingly high by general market standards.
Volatility Risk: CRS exhibits elevated volatility risk, as evidenced by a beta of 1.267, indicating it is approximately 27% more volatile than the broader market. This heightened sensitivity is corroborated by a significant 1-year maximum drawdown of -28.11%, suggesting the potential for substantial price declines during market downturns.
Other Risks: The absence of reported short interest implies no significant speculative pressure betting against the stock. However, investors should assess liquidity metrics and other firm-specific factors such as industry competition or operational performance, as these could represent primary risk drivers in lieu of short-selling activity.
Bullish - CRS presents a compelling opportunity despite valuation concerns. Strong aerospace demand and consistent earnings beats drive growth, supported by a solid balance sheet and positive analyst sentiment. This stock suits momentum investors and those bullish on the aerospace cycle, but may be too rich for strict value investors given its elevated multiples.
Based on the metrics provided, CRS stock appears to be significantly overvalued. Key valuation ratios are extremely high by general market standards, including a P/E of 42.94, a P/B of 9.4, and a deeply negative PEG ratio of -2.62. This overvaluation is primarily due to the market pricing in very high growth expectations that are not supported by the company's current modest revenue decline and moderate operational efficiency (e.g., ROE of 5.3%). While the company has a strong balance sheet and profitability, these positive fundamentals are not sufficient to justify the exceptionally high price multiples.
Based on the provided information, here are the key risks of holding CRS stock, ordered by importance:
1. Market Volatility Risk: The stock's high beta of 1.267 makes it significantly more volatile than the market, exposing it to larger potential losses during broad market downturns, as evidenced by its recent -28.11% maximum drawdown. 2. Business/Operational Risk: A slight quarterly revenue decline combined with a lengthy 172-day cash conversion cycle (primarily due to 145 days of inventory) indicates potential operational inefficiencies and vulnerability to slowing demand. 3. Valuation/Timing Risk: The stock is trading at 96% of its 52-week high, suggesting an overbought condition that increases the risk of a price correction, especially following its period of exceptional bullish momentum.
Based on its strong positioning in aerospace & defense and operational improvements, CRS is forecast to see moderate growth by 2026. Our base case target is $400-450, with a bull case of $500+ if margin expansion accelerates. Key drivers include sustained demand from the commercial aerospace cycle and improved efficiency in working capital management. Major assumptions are a stable macroeconomic environment and no significant downturn in its core markets. This forecast is highly uncertain given the stock's current premium valuation, which leaves it vulnerable to a correction if earnings growth disappoints.